Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine

NCT01005238 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped unsufficient patient recruitment

Conditions

Hepatitis, Chronic

Interventions

DRUG: Lamivudine
DRUG: Telbivudine

Sponsor

University Hospital, Basel, Switzerland